Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL)

CUSIP: 04537Y208

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
42,091,923
Total 13F shares
110,574
Share change
-719,497
Total reported value
$15,747
Price per share
$0.14
Number of holders
2
Value change
-$65,444
Number of buys
1
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 04537Y208?
CUSIP 04537Y208 identifies AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Robert H. Drysdale
3/4/5
10%+ Owner
class O/S missing
1,310,531
$4,416,489 28 Nov 2023
James T. LaFrance
3/4/5
Director
mixed-class rows
606,434
mixed-class rows
$2,024,931 31 Mar 2022
Robert D. Auerbach
3/4/5
Director
mixed-class rows
375,462
mixed-class rows
$1,228,683 09 Feb 2023
Ruby Sharma
3/4/5
Director
mixed-class rows
358,961
mixed-class rows
$1,176,328 09 Feb 2023
Valerie Barber Palmieri
3/4/5
Executive Chair, Director
class O/S missing
267,088
$900,087 16 May 2022
Nicole Sandford
3/4/5
Chief Executive Officer, Director
mixed-class rows
201,740
mixed-class rows
$518,977 28 Oct 2024
Robert Harry Beechey
3/4/5
Chief Financial Officer
class O/S missing
150,000
$480,000 31 Mar 2022
Torsten Hombeck
3/4/5
Chief Financial Officer
mixed-class rows
55,000
mixed-class rows
$181,610 13 May 2024
Veronica Gh Jordan
3/4/5
Director
class O/S missing
41,620
$140,259 25 Jul 2023
Minh Hoang Merchant
3/4/5
General Counsel and Secretary
mixed-class rows
37,865
mixed-class rows
$125,735 14 Feb 2024
Sandra Milligan
3/4/5
Interim CEO
mixed-class rows
38,644
mixed-class rows
$105,551 31 Dec 2024
John A. Kallassy
3/4/5
Interim CFO
mixed-class rows
50,000
mixed-class rows
$80,000 12 Nov 2024
Marlene McLennan
3/4/5
Interim Chief Financial Office
class O/S missing
25,000
$80,000 01 Dec 2022
Celeste Rachelle Fralick
3/4/5
Director
mixed-class rows
60,665
mixed-class rows
$42,466 31 Mar 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
800,797
$24,024 $0 31 Dec 2024
HRT FINANCIAL LP
13F
Company
0.43%
182,286
$17,000 31 Mar 2025
13F
Ryan Thinh Phan
3/4/5
CSO & COO
class O/S missing
3,939
$13,274 24 Jul 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
131,968
$12,393 31 Mar 2025
13F
Jannie Prestridge Herchuk
3/4/5
Director
mixed-class rows
87,404
mixed-class rows
$8,381 04 Jun 2025
BlackRock, Inc.
13F
Company
0.2%
82,232
$7,722 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
0.19%
79,183
$7,443 31 Mar 2025
13F
John Phillip Ragard
3/4/5
Director
0.32%
134,734
mixed-class rows
$7,433 04 Jun 2025
Stefanie L. Cavanaugh
3/4/5
Director
mixed-class rows
81,994
mixed-class rows
$6,517 04 Jun 2025
Ellen O'Connor Vos
3/4/5
Director
mixed-class rows
77,257
mixed-class rows
$5,937 04 Jun 2025
BANK OF AMERICA CORP /DE/
13F
Company
0.15%
63,527
$5,908 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
0.15%
62,184
$5,839 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
0.13%
52,851
$5,000 31 Mar 2025
13F
UBS Group AG
13F
Company
0.08%
34,196
$3,214 31 Mar 2025
13F
Pine Valley Investments Ltd Liability Co
13F
Company
0.08%
33,400
$3,137 31 Mar 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.07%
29,808
$2,799 31 Mar 2025
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.06%
25,000
$2,350 31 Mar 2025
13F
Northeast Financial Consultants Inc
13F
Company
0.06%
23,436
$2,201 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.05%
19,749
$1,854 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.04%
16,799
$1,577 31 Mar 2025
13F
M&T BANK CORP
13F
Company
0.04%
14,999
$1,410 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
4,130
$388 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
2,650
$240 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
2,061
$194 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0%
1,694
$159 31 Mar 2025
13F
Operose Advisors LLC
13F
Company
0%
1,000
$94 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
610
$57 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
199
$19 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0%
119
$11 31 Mar 2025
13F
Michael William Buhle
3/4/5
Chief Executive Officer
class O/S missing
100,000
22 May 2025

Institutional Holders of Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL) as of Q2 2025

As of 30 Jun 2025, Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 110,574 shares. The largest 2 holders included OSAIC HOLDINGS, INC. and XTX Topco Ltd. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
22
Q2 2025 holders
2
Holder diff
-20
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .